论文信息 - Phase I Trial of Intratumoral Injection of CCL21 Gene–Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration - 字舞流文

Phase I Trial of Intratumoral Injection of CCL21 Gene–Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration

F. Marincola | F. Abtin | R. Suh | D. Elashoff | W. Wallace | S. Adams | Gina Lee | S. Dubinett | G. Zeng | Sherven Sharma | J. Goldman | E. Garon | P. Tumeh | K. Reckamp | J. Yanagawa | Stacy J. Park | D. Schaue | Jay M. Lee | Ying Q Lin | Tonya C. Walser | Ying Q. Lin | Felicita E. Baratelli | Frances Rosen | Gerald Wang | T. Walser | R. Salehi-Rad | Sarah Lee | Mi-Heon Lee | Sherven P Sharma